In the Margins
Concentrated bets on individual stocks raise issues for mutual funds and their investors—a matter highlighted last week at Sequoia Fund, one of the biggest investors in controversial drug maker Valeant Pharmaceuticals International Inc. Placing outsize bets on well-chosen stocks can lead to strong performance, but concentration increases the riskiness of a fund and raises questions about how much is too much. Read the original story from The Wall Street Journal.
Most Read
Independent mutual fund directors saw markedly smaller increases in pay in 2017, when compared to the year prior, according to the results of the Independent Directors ...
The parties in a 2014 lawsuit accusing PIMCO of overcharging Total Return Fund shareholders while lavishly compensating CIO Bill Gross and CEO Mohamed El-Erian agreed this week ...
The board of T. Rowe Price Group's funds has elected an independent chairman for the first time, naming Robert Gerrard to the top spot at the ...
Merger & acquisition activity in the asset management business has been ticking up for years, and it doesn't look to be slowing down anytime soon. And ...